Jane Street Group, LLC Blueprint Medicines Corp Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 189,137 shares of BPMC stock, worth $21.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,137
Previous 142,357
32.86%
Holding current value
$21.1 Million
Previous $15.3 Million
13.97%
% of portfolio
0.0%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding BPMC
# of Institutions
354Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$745 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$741 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$601 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$442 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$308 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.66B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...